National Institute for Innovation in Manufacturing Biopharmaceuticals
Newark · Founded 2017
About National Institute for Innovation in Manufacturing Biopharmaceuticals
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a public-private partnership whose mission is to accelerate biopharmaceutical innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S. competitiveness in this industry. NIIMBL is part of Manufacturing USA®, a diverse network of federally-sponsored manufacturing innovation institutes, and is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST) in the U.S. Department of Commerce with significant additional support from its members.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $173.5M
- Last round: Grant (Oct 2025)
- Website: niimbl.org
- Phone: (302) 831-0663
Industries & Categories
Biotechnology, Health Care, Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/national-institute-for-innovation-in-manufacturing-biopharmaceuticals-78402 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.